ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,036, issued on June 17, was assigned to RIGEL PHARMACEUTICALS INC. (South San Francisco, Calif.).
"Heterocyclic RIP1 kinase inhibitors" was invented by Simon Shaw (Oakland, Calif.), Somasekhar Bhamidipati (Foster City, Calif.) and Vanessa Taylor (San Francisco).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are kinase inhibitory compounds, such as a receptor-interacting protein-1 (RIP1) kinase inhibitor compounds, as well as pharmaceutical compositions and combinations comprising such inhibitory compounds. The disclosed compounds, pharmaceutical compositions, and/or combinations may be used to treat or prevent a kinase-associated dis...